• Sponsor & Exhibit Opportunities Available
  • The Longest Running HCA Meeting


About The Event

CHI’s Thirteenth Annual High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies, returns to San Diego with a new program. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The High-Content Analysis meeting will focus on the next steps of technology development, including screening of 3D and physiologically relevant complex models, ultra-high resolution and high-throughput imaging, more advanced image analysis and data management, and new assays and applications. The co-located Second Annual Phenotypic Screening meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma. Join the original High-Content Analysis event and get access to two tracks featuring a cutting-edge scientific agenda, expanded exhibit hall and technology showcases, and an offering of user group meetings and dinner courses.

Now Accepting Speaker Proposals

Cambridge Healthtech Institute is currently accepting speaker proposals for the longest-running High-Content Analysis meeting and co-located Phenotypic Screening conference. Thought leaders and researchers in the field are encouraged to submit a proposal to present by Friday, July 24, 2015.

Submit Your Proposal 

High-Content Analysis Topics Include:               

Phenotypic Screening Topics Include:  

- Phenotypic Drug Discovery
- Ultra-High Resolution Imaging
- HCA in 3D Cell Models, Tissues and Animal Models
- Image Analysis and Data Management
- New Biological Models for HCA
- Live-Cell Imaging
- High-Content Flow Cytometry
- High-Content Screening for Safety Profiling

- Case Studies in Phenotypic Screening
- Phenotypic Screening Using 3D Models
- Assay Development for Screening 3D Models
- Target/Pathway Identification and Validation
- Physiologically Relevant Models for Phenotypic Screening
- Data Analysis for Phenotypic Screening
- Chemical Genomics and Chemical Proteomics
- Quantitative Systems Pharmacology